Korro Bio is laying off a fifth of its workforce as the Novo Nordisk-partnered biotech funnels resources to its ...

Me’s bankruptcy could put millions of Americans’ genomic profiles at risk of being sold to the Chinese Communist Party, who ...

Learn about April 2025’s top biotech deals, featuring major collaborations in bispecific antibodies, protein therapies, and ...

A health insurer has teamed up with biotech firm CariGenetics to offer improved nutrition and fitness to its clients.

What if business leaders approached strategy the way scientists design gene delivery vectors? In biotechnology, precision, ...

The companies Biohaven, MoonLake Immunotherapeutics, and AIRNA bagged the biggest biotech funding rounds overall in April ...

Biotechnology company Colossal Biosciences used genetic editing techniques to alter 20 genes of gray wolves (pictured above) to express certain characteristics of ancient dire wolves. The company ...

Announce initial clinical data from Cohort 1 in the Phase 1/2 trial of PM359 for p47 phox CGD in 2025. The initial readout ...

Despite the immense potential of gene therapies, drugmakers have soured on the field. So an ambitious charity is trying to ...

Vir Biotechnology (VIR) delivered earnings and revenue surprises of -6.02% and 84.51%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

In the headquarters of a mid-sized pharmaceutical company preparing for its first product launch, a scene once considered ...